NMC

NEA Management Company Portfolio holdings

AUM $1.33B
1-Year Return 85.82%
This Quarter Return
+24.51%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$1.93B
AUM Growth
-$596M
Cap. Flow
-$796M
Cap. Flow %
-41.31%
Top 10 Hldgs %
67.29%
Holding
46
New
Increased
6
Reduced
1
Closed
1
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SURF
26
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$15.8M 0.82%
3,315,149
CSBR icon
27
Champions Oncology
CSBR
$95.4M
$15.3M 0.79%
1,562,500
LXRX icon
28
Lexicon Pharmaceuticals
LXRX
$389M
$13.2M 0.69%
2,382,286
BE icon
29
Bloom Energy
BE
$12.8B
$12.2M 0.63%
1,333,333
ARQL
30
DELISTED
Arqule Inc
ARQL
$12.1M 0.63%
2,520,316
DZSI
31
DELISTED
DZS Inc. Common Stock
DZSI
$10.2M 0.53%
956,255
RIGL icon
32
Rigel Pharmaceuticals
RIGL
$720M
$8.34M 0.43%
324,315
VRNA
33
Verona Pharma
VRNA
$9.19B
$7.93M 0.41%
1,219,674
KA
34
DELISTED
Kineta, Inc. Common Stock
KA
$7M 0.36%
39,691
TRVN
35
DELISTED
Trevena, Inc.
TRVN
$5.95M 0.31%
6,099
XFOR icon
36
X4 Pharmaceuticals
XFOR
$81.7M
$5.8M 0.3%
11,111
TCON
37
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$4.75M 0.25%
17,336
PHXM
38
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$4.74M 0.25%
62,500
CTIC
39
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$3.64M 0.19%
3,750,000
AKAO
40
DELISTED
Achaogen, Inc.
AKAO
$2.35M 0.12%
5,215,128
ELGX
41
DELISTED
Endologix Inc
ELGX
$1.65M 0.09%
249,021
+1
+0% +$7
AKTX
42
Akari Therapeutics
AKTX
$23.8M
$1.62M 0.08%
22,608
VIRX
43
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$1.58M 0.08%
37,094
TRIL
44
DELISTED
Trillium Therapeutics Inc.
TRIL
$1.39M 0.07%
2,100,000
+850,000
+68% +$561K
RGLS
45
DELISTED
Regulus Therapeutics
RGLS
$934K 0.05%
91,575
TSRO
46
DELISTED
TESARO, Inc.
TSRO
-10,420,555
Closed -$774M